Related Experiment Video

Updated: Aug 18, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Advances in paediatric rheumatology: beyond NSAIDs and joint replacement

J E Munro1, K J Murray

  • 1Department of General Paediatrics, Royal Children's Hospital, Parkville, Victoria, Australia.

Journal of Paediatrics and Child Health
|March 11, 2004
PubMed

Insights

Significant advancements in understanding and treating childhood rheumatic diseases have been made over 30 years. Current treatments offer disease control and remission for many pediatric arthritis patients.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Understanding of childhood rheumatic diseases' pathogenesis and epidemiology has evolved significantly over three decades.
  • Improvements in classification and international research collaboration have driven progress.

Purpose of the Study:

  • To review advancements in the understanding, classification, and treatment of pediatric-onset rheumatic diseases.
  • To identify current challenges and future directions in managing these chronic conditions.

Main Methods:

  • Review of recent literature and clinical advancements in pediatric rheumatology.
  • Analysis of changes in disease classification and therapeutic strategies.
  • Discussion of collaborative research outcomes and their impact.

Main Results:

  • Development of new therapeutic agents and improved outcome assessment methods.
  • Availability of treatment regimens providing disease control and remission for many children.
  • Identification of key challenges in genetics, pathogenesis, and biomarker discovery.

Conclusions:

  • Current treatments offer significant benefits for children with rheumatic diseases.
  • Further research is needed for precise diagnosis, prognosis, and development of superior therapies.
  • Future efforts should focus on personalized medicine for optimal patient outcomes.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Automated Joint Space Detection Improves Bone Segmentation Accuracy06:45

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...